Fundamental - Factsheet
Thomson Medical THOMSON MEDICAL GROUP LIMITED
Quotes 10 Minutes Delayed. Updated at 01 Sep 2021 17:06
|Last (SGD): 0.086||Change: -||High: 0.086||Remarks: -|
|Change (%): -||Low: 0.085|
|Buy Price||0.085||Sell Price||0.086|
|Buy Volume (000)||4,904.6||Sell Volume (000)||1,588.8|
|Cumulative Volume (000)||4,790.6||Cumulative Value||410,035|
30 Aug 2021 09:00
27 Aug 2021 19:54
27 Aug 2021 17:54
27 Aug 2021 17:45
24 Aug 2021 19:20
14 Jun 2021 09:00
31 May 2021 18:48
25 May 2021 18:15
|EPS (SGD) a , m||-0.00375||Trailing EPS (SGD) e||-0.00338||NAV (SGD) b||0.0186|
|PE a , m||-||Trailing PE f||-||Price / NAV b||4.6237|
|Dividend (SGD) d , m||-||Cash In Hand (SGD) g||0.0041||Issued & Paid-up Shares c||26,441,017,000|
|Dividend Yield (%) d , m||-||Price / Cash In Hand g||20.976||Treasury Shares h||-|
|Beta - 75 Daysi||1.163||R-Squared - 75 Days(%)i||10.65||Market Cap (M)||2,273.927|
|Beta - 500 Daysi||0.742||R-Squared - 500 Days (%)i||7.96||Enterprise Value (M)||2,855.879|
|Piotroski F Score||5||Exchange Code||A50||Par Value ( SGD )||n.a.|
|52 Weeks Volatility (%)||66.0822||6-Month VWAP||0.102||Free Float (%)||11.2|
|Under CPF Investment Scheme (CPFIS)||No|
|Sector & Industry||Health and Social Services - Investment Trusts/Mutual Funds|
|Category Classification||Medical & Biotechnology / Property & Construction|
|Index Components||FTSE ST All-Share Health Care Index / FTSE ST All-Share Index / FTSE ST Large/Mid Cap Index / FTSE ST Mid Cap Index|
Based on latest Full Year results announcement, adjusted for the current number of shares.
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of Other Share Capital, illustrative financial effects of corporate actions (if applicable) and the current number of shares.
Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 22 Feb 2021.Please click here for more information.
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
Based on Trailing EPS.
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
Rounded to the nearest thousand.
Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.
Length of financial period for latest Full Year is 18 months.
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders Equity) of all companies in the industry/index.
Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
Industry/Index/Peers data is updated daily.
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
Total Shareholder Return
|Period||Dividend Received||Capital Appreciation||Total Shareholder Return|
|Short Term Return||5 Days||-||-0.001||-1.15 %|
|10 Days||-||-0.002||-2.27 %|
|Medium Term Return||3 Months||-||-0.002||-2.27 %|
|6 Months||-||-0.025||-22.52 %|
|1 Year||-||+0.033||+62.26 %|
|Long Term Return||2 Years||-||+0.028||+48.28 %|
|3 Years||-||+0.009||+11.69 %|
|5 Years||-||-0.011||-11.34 %|
|Annualised Return||Annualised||-||-||-2.38 %|
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
Script dividends are ignored in this calculation.
|1 Year Range||0.045 - 0.125||Change From 1 Year Low||+0.041||% Change From 1 Year Low (%)||+91.11|
|Change From 1 Year High||-0.039||% Change From 1 Year High (%)||-31.20|
|2 Years Range||0.038 - 0.125||Change From 2 Years Low||+0.048||% Change From 2 Years Low (%)||+126.32|
|Change From 2 Years High||-0.039||% Change From 2 Years High (%)||-31.20|
|5 Years Range||0.038 - 0.164||Change From 5 Years Low||+0.048||% Change From 5 Years Low (%)||+126.32|
|Change From 5 Years High||-0.078||% Change From 5 Years High (%)||-47.62|
Price movements are based on adjusted historical data.
Listed on the Mainboard of the Singapore Exchange, Thomson Medical Group Limited (SGX: A50) is one of the leading listed healthcare players in the South-East Asian region with operations in Singapore and Malaysia.Established in 1979, the Groups Thomson Medical Pte Ltd is one of the largest private provider of healthcare services for women and children in Singapore. It owns and operates the iconic Thomson Medical Centre and a network of specialist medical clinics and facilities providing outpatient women and children healthcare services and service offerings in diagnostic imaging, health screening, gynaecological oncology, dentistry, specialist dermatology, traditional Chinese medicine, musculoskeletal and sports medicine, and medical aesthetics.The Groups operations in Malaysia under TMC Life Sciences Berhad is a multi-disciplinary healthcare company listed on Bursa Malaysia. It operates Thomson Hospital Kota Damansara, a tertiary hospital located in Kota Damansara, and the award-winning TMC Fertility Centre which is the industry leader in assisted reproduction in Malaysia. It also owns the proposed Thomson Iskandar Medical Hub, in Johor Bahru, Malaysia.The Group also owns a prime 9.23 ha freehold waterfront land, strategically located in Johor Bahrus City Centre, with a proposed long term plan to build an integrated healthcare city to meet the growing healthcare needs of the people in the region.
|Listing Date||10 Jul 2002||Full Subscription Rate (x)||3.70|
|No of Placement Shares (M)||46.90||No of Public Offer Shares (M)||20.10||Public Offer Subscription Rate (x)||10.00|
|IPO Price (SGD) a||0.075||First Day Close (SGD) a||0.111||First Week Close (SGD) a||0.108|
|Current vs IPO Price (%)||+14.67||First Day Gain (%)||+48.00||First Week Gain (%)||+44.00|
Adjusted for the following: Rights Issue 2 for 5 @ $0.06 on 21/08/2009, Bonus Issue 2 WT for 1 SH @ Exercise Price of $0.180/WT for 1 NEW SH on 01/10/2013, Bonus Issue 2 FREE WT for 1 SH @ Exercise Price of S$0.09/WT for 1 NEW SH on 16/04/2018
More Information Available
More information is available to our subscribers, including:
- Market Moving News from Dow Jones Newswires
- Consensus Estimates
- Dividend/Distribution History
- Financial Summary with Financial Period Comparison
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Events Calendar for Results Announcements, Ex-Dates etc
- Insider Buying and Selling Report
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
Find us at the office
Zawodniak- Bushar street no. 43, 41415 Nouakchott, Mauritania
Give us a ring
+77 583 658 542
Mon - Fri, 10:00-15:00